1084 related articles for article (PubMed ID: 29186567)
1. Dynamic m6A modification regulates local translation of mRNA in axons.
Yu J; Chen M; Huang H; Zhu J; Song H; Zhu J; Park J; Ji SJ
Nucleic Acids Res; 2018 Feb; 46(3):1412-1423. PubMed ID: 29186567
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
3. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
4. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
5. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Yang Y; Shen F; Huang W; Qin S; Huang JT; Sergi C; Yuan BF; Liu SM
J Clin Endocrinol Metab; 2019 Mar; 104(3):665-673. PubMed ID: 30137347
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3'-end processing.
Bartosovic M; Molares HC; Gregorova P; Hrossova D; Kudla G; Vanacova S
Nucleic Acids Res; 2017 Nov; 45(19):11356-11370. PubMed ID: 28977517
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
8. RNA demethylation by FTO stabilizes the FOXJ1 mRNA for proper motile ciliogenesis.
Kim H; Lee YS; Kim SM; Jang S; Choi H; Lee JW; Kim TD; Kim VN
Dev Cell; 2021 Apr; 56(8):1118-1130.e6. PubMed ID: 33761320
[TBL] [Abstract][Full Text] [Related]
9. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis.
Zhao X; Yang Y; Sun BF; Shi Y; Yang X; Xiao W; Hao YJ; Ping XL; Chen YS; Wang WJ; Jin KX; Wang X; Huang CM; Fu Y; Ge XM; Song SH; Jeong HS; Yanagisawa H; Niu Y; Jia GF; Wu W; Tong WM; Okamoto A; He C; Rendtlew Danielsen JM; Wang XJ; Yang YG
Cell Res; 2014 Dec; 24(12):1403-19. PubMed ID: 25412662
[TBL] [Abstract][Full Text] [Related]
10. The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging.
Jiang ZX; Wang YN; Li ZY; Dai ZH; He Y; Chu K; Gu JY; Ji YX; Sun NX; Yang F; Li W
Cell Death Dis; 2021 Jul; 12(8):744. PubMed ID: 34315853
[TBL] [Abstract][Full Text] [Related]
11. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
12. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells.
Tang S; Meng J; Tan J; Liu X; Zhou H; Li N; Hou S
Clin Immunol; 2022 Aug; 241():109080. PubMed ID: 35878734
[TBL] [Abstract][Full Text] [Related]
15. NADP modulates RNA m
Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
[TBL] [Abstract][Full Text] [Related]
16. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J
J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) as a Novel Mediator of Statin Effects in Human Endothelial Cells.
Mo W; Chen Z; Zhang X; Dai G; Ma D; Pan J; Zhang X; Wu G; Fan W
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):644-658. PubMed ID: 35296150
[TBL] [Abstract][Full Text] [Related]
18. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S
J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823
[TBL] [Abstract][Full Text] [Related]
19. m6A Demethylase FTO Regulates Dopaminergic Neurotransmission Deficits Caused by Arsenite.
Bai L; Tang Q; Zou Z; Meng P; Tu B; Xia Y; Cheng S; Zhang L; Yang K; Mu S; Wang X; Qin X; Lv B; Cao X; Qin Q; Jiang X; Chen C
Toxicol Sci; 2018 Oct; 165(2):431-446. PubMed ID: 29982692
[TBL] [Abstract][Full Text] [Related]
20. Identification of Specific
Zhang Y; Li QN; Zhou K; Xu Q; Zhang CY
Anal Chem; 2020 Oct; 92(20):13936-13944. PubMed ID: 32972135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]